| Bioactivity | 7-(2,3-Anhydro-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 7-(2,3-Anhydro-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
| CAS | 40627-31-4 |
| Formula | C11H12N4O3 |
| Molar Mass | 248.24 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
7-(2,3-Anhydro-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS: 40627-31-4 F: C11H12N4O3 W: 248.24
7-(2,3-Anhydro-β-D-ribofuranosyl)-7H-pyrrolopyrimidin-4-amine is a purine nucleoside analogue. Purine nucleoside analog
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.